Protein kinase inhibitors
US7855211B2 · kind B2 · utility
39Cited by
0References
23Claims
0Family size
Assignee
Inventors
- David Coates
- Lawrence Mark Gelbert
- John Monte Knobeloch
- Alfonso De Dios Magana
- Ana De Prado Gonzalez
- Miriam Filadelfa Del Prado Catalina
- Maria Cristina Garcia Paredes
- Eva Maria Martin De La Nava
- Maria Dolores Martin Ortega Finger
- Jose Antonio MARTINEZ PEREZ
- Ana Isabel Mateo Herranz
- Carlos PEREZ MARTINEZ
- Concepcion Sanchez Martinez
Key dates
| Filing date | Dec 15, 2009 |
| Grant date | Dec 21, 2010 |
| Priority date | — |
| Expiry date | Dec 15, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I):or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.